Medscape September 11, 2024
Sarah Amandolare

This is the third in a three-part series from Medscape on the impact of AI on drug discovery and development. Part 1 is about AI’s role in designing speedier, more effective clinical trials. Part 2 is about the use of AI to find new applications for existing drugs.

What if we told you that the same technology behind deepfake photos could soon bring new and improved drugs to your patients?

Unlike some of those photos, that’s not fake news.

Researchers are borrowing from artificial intelligence (AI) models, such as OpenAI’s DALL-E, that translate text into images to design never-before-seen proteins from scratch. These designs could form the basis of future drugs or vaccines.

“For the first...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article